29
Views
18
CrossRef citations to date
0
Altmetric
Research Article

TNP-470 Inhibits Oxidative Stress, Nitric Oxide Production and Nuclear Factor Kappa B Activation in a Rat Model of Hepatocellular Carcinoma

, , , , , , & show all
Pages 841-848 | Published online: 07 Jul 2009

References

  • Liekens, S., De Clercq, E. and Neyts, J. (2001) "Angiogenesis: regulators and clinical applications", Biochem. Pharmacol. 61, 253–270.
  • Yoshida, A., Anand-Apte, B. and Zetter, B.R. (1996) "Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor", Growth Factors 13, 57–64.
  • Sasaki, A., Alcalde, R.E., Nishiyama, A., Lim, D.D., Mese, H., Akedo, H. and Matsumura, T. (1998) "Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption", Cancer Res. 58, 462–467.
  • Liekens, S., Verbeken, E., Vandeputte, M., De Clercq, E. and Neyts, J. (1999) "A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470", Cancer Res. 59, 2376–2383.
  • Turk, B.E., Griffith, E.C., Wolf, S., Biemann, K., Chang, Y.H. and Liu, J.Q. (1999) "Selective inhibition of amino-terminal methionine processing by TNP-470 and ovacilin in endo-thelial cells", Chem. Biol. 6, 823–833.
  • Morales, C., Zurita, M. and Vaquero, J. (2002) "Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malign at neuroectodermic tumor", J. Neurooncol. 58, 131–136.
  • Gervaz, P., Scholl, B., Padrum, V. and Gillet, M. (2000) "Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470", Liver 20, 108–113.
  • Toyokuni, S., Okamoto, K., Yodoi, J. and Hiai, H. (1995) "Persistent oxidative stress in cancer", FEBS Lett. 358, 1–3.
  • Fiander, H. and Schneider, H. (2000) "Dietary ortho phenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: the allevia-tion of oxidative stress and detoxification of mutagenic xenobiotics", Cancer Lett. 156, 117–124.
  • Hensley, K., Robinson, K.A., Gabbita, S.P., Salsman, S. and Floyd, R.A. (2000) "Reactive oxygen species, cell signalling, and cell injury", Free Radic. Biol. Med. 28, 1456–1462.
  • Van den Berg, R., Haenen, G.R., Van den Berg, H. and Bast, A. (2001) "Transcription factor NF-KB as a potential biomarker for oxidative stress", Br. J. Nutr. 86, S121 —S127.
  • Shibata, A., Nagaya, T., Imai, R., Funahashi, H., Nakao, A. and Seo, H. (2002) "Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells", Breast Cancer Res. Treat. 73, 237–243.
  • Liu, E, Kimmoun, E., Legrand, A., Sauvanet, A., Degott, C., Lardeux, B. and Bernuau, D. (2002) "Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas", J. Hepatol. 37, 63–71.
  • Hur, G.M., Ryu, Y.S., Yun, H.Y., Jeon, B.H., Kim, Y.M., Seok, J.H. and Lee, J.H. (1999) "Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-KB", Biochem. Biophys. Res. Commun. 261, 917–922.
  • Ziche, M. and Morbidelli, L. (2000) "Nitric oxide and angiogenesis", J. Neurooncol. 50, 139–148.
  • Liaudet, L., Garcia-Soriano, F. and Szabo, C. (2000) "Biology of nitric oxide signalling", Crit. Care Med. 28, N37—N52.
  • Acker, T. and Plate, K.H. (2002) "A role for hypoxia-inducible transcription factors in tumor physiology", J. Mol. Med. 80, 562–575.
  • Solt, D. and Farber, E. (1976) "New principle for the analysis of chemical carcinogenesis", Nature 263, 701–703.
  • Higgins, G.F. and Anderson, R.M. (1931) "Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal", Arch. Pathol. 12, 186–202.
  • Hissin, P.J. and Hilf, R.A. (1976) "Fluorimetric method for determination of oxidised and reduced glutathione in tissues", Anal. Biochem. 74, 214–226.
  • Ohkawa, H., Ohishi, N. and Yagi, K. (1979) "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction", Anal. Biochem. 95, 351–358.
  • Monte, M.J., Palomero, M., Sainz, G.R., Dominguez, M., Diez, M., Torafto, A. and Marin, J.J.G. (2000) "Bile acid secretion during rat liver carcinogenesis", Life Sci. 66, 1085–1095.
  • Essani, N.A., McGuire, G.M., Manning, A.M. and Jaeschke, H. (1996) "Endotoxin-induced activation of the nuclear tran-scription factor NF-KB in hepatocytes, Kupffer cells and endothelial cells in vivo", J. Immunol. 156, 2956.
  • Monte, M.J., Dominguez, S., Palomero, M.F., Macias, R.I. and Mann, J.J.G. (1999) "Further evidence of the uselfulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors", J. Hepatol. 31, 521–528.
  • Sato, K. (1989) "Glutathione trasnferases as markers of preneoplasia and neoplasia", Adv. Cancer Res. 52, 205–255.
  • Imai, T., Masui, T., Ichinose, M., Nakanishi, H., Yanai, T., Masegi, T., Muramatsu, M. and Tatematsu, M. (1997) "Reduction of glutathione S-transferase P-form mRNA expression in remodelling nodules in rat liver revealed by in situ hybridisation", Carcinogenesis 18, 545–551.
  • Tsuzuki, S., Yamauchi, A., Nakamura, H., Kinoshita, K., Gomi, T., Tanaka, K., Inamoto, T. and Yamaoka, Y. (1998) "Possible availability of N-cetylcysteine as an adjunct to cytokine therapy for hepatocellular carcinoma", Clin. Immu-nol. Immunopathol. 88, 192–198.
  • Navarro, J., Obrador, E., Carretero, J., Petschen, I., Avirio, J., Perez, P. and Estrela, J.M. (1999) "Changes in glutathione status and the antioxidant system in blood and in cancer cells associated with tumour growth in vivo", Free Radic. Biol. Med. 26, 410–418.
  • Huang, Z.Z., Chen, C., Zeng, Z., Yang, H., Oh, J., Chen, L. and Lu, S.C. (2001) "Mechanisms and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration", FASEB J. 15, 19–21.
  • Terradez, P., Asensi, M., Lasso de la Vega, M.C., Puertes, I.R., Viaia, J. and Estrela, J.M. (1993) "Depletion of tumour glutathione in vivo by buthionine sulfoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth", Biochem. J. 292, 477–483.
  • Son, H.J., Kim, Y.H., Park, DJ., Kim, J.J., Rhee,Paik, S.W.,Choi, K.W., Song, S.Y. and Rhee, J.C. (2001) "Interaction between cyclooxygenase-2 and inducible nitric oxide syntahse in gastric cancer", J. Clin. Gastroenterol. 33, 383–388.
  • Doi, K., Akaike, T., Hone, H., Noguchi, Y, Fujii, S., Beppu, T., Ogawa, M. and Maeda, H. (1996) "Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth", Cancer 77, 1598–1604.
  • Maeda, H. and Akaike, T. (1998) "Nitric oxide and oxygen radical in infection, inflammation and cancer", Biochemistry 63, 854–856.
  • Liu, T.Z., Hu, C.C., Andrew, C., Chen, Y., Stern, A. and Cheng, J.T. (2000) "Differentiation status modulates transcription factor NF-kB activity in unstimulated human hepatocellular carcinoma cell lines", Cancer Lett. 151, 49–56.
  • Locigno, R., Antoine, N., Bours, V, Daukandt, M., Heinen, E. and Castronovo, V. (2000) "TNP-470, a potent angiogenesis inhibitor, amplifies human lymphocyte activation through an induction of nuclear factor-kB, nuclear factor AT, and activation protrein-1 transcription factor", Lab. Investig. 80, 13–21.
  • Dhar, A., Young, M.R. and Colburn, N.H. (2002) "The role of AP-1, NF-kappa B and ROS /NOS in skin carcinogenesis: the JB6 model is predictive", Mol. Cell. Biochem., 234–235, 185–193.
  • Kin, M., Torimura, T., Ueno, T., Nakamura, T., Ogata, R., Sakamoto, M., Tamaki, S. and Sata, M. (2000) "Angiogenesis inhibitor TNP-470 suppresses the progression of experiment-ally-induced hepatocellular carcinoma in rats", Int. J. Oncol. 16, 375–382.
  • Irving, M.G., Roll, F.J., Huang, S. and Bissell, D.M. (1984) "Characterization and culture of sinusoidal endothelium form normal rat liver: lipoprotein uptake and collagen phenotype", Gastroenterology 87, 1233–1247.
  • Kin, M., Torimura, T., Ueno, T., Inuzuka, S. and Tanikawa, K. (1994) "Sinusoidal capillarization in small hepatocellular carcinoma", Pathol. Int. 44, 771–778.
  • Takami, S., Ueno, T., Torimura, T., Sata, M. and Tanikawa, K. (1996) "Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endotelial cells in rats with liver cirrosis", Gastroenterology 114, 1049–1057.
  • Folkman, J. (2001) "Angiogenesis-dependent diseases", Semin. Oncol. 28, 536–542.
  • Folkman, J., Browder, T. and Palmblad, J. (2001) "Angiogene-sis research: guidelines for translation to clinical application", Thromb. Haemost. 86, 23–33.
  • Wang, Y.Q., Ikeda, K., Ikebe, T., Hirakawa, K., Sowa, M., Nakatani, K., Kawada, N. and Kaneda, K. (2000) "Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats", Hepatology 32, 980–989.
  • Castronovo, V. and Belotti, D. (1996) "TNP-470. Mechanisms of action and early clinical development", Fur. J. Cancer 32A, 2520–2527.
  • Ahmed, M.H., Konno, H., Nahar, L., Tanaka, T., Naito, Y., Nakamura, S. and Baba, S. (1996) "The angiogenesis inhibitor TNP-470 (AGM-1470) imrpoves long-term survival of rats with liver metastases", J. Surg. Res. 64, 35–41.
  • Smyth, J.F., Bowman, A., Perren, T., Wilkinson, P., Prescott, R.J., Quim, K.J. and Tedeschi, K.M. (1997) "Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplastin: results of a double-blind, randomised trial", Ann. Oncol. 8, 569–573.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.